HEALTHCARE · NSE/BSE: NH

Narayana Hrudayalaya Ltd. Earnings Summary — Q4 FY2026

Sentiment: Positive
AI-generated summary
Generated 2026-06-23
Business Intelligence Report

Narayana Hrudayalaya Reports Massive 108% Revenue Surge with Robust Operational Profit Growth in Q4

Quarterly Business Intelligence

Q1 FY2027
Financials from Financial Intelligence · data as of 2026-06-30
Revenue
₹2,684 Cr
QoQ +3.5%YoY +78.0%
Net Profit
₹207 Cr
QoQ -7.5%YoY +5.4%
Operating Profit
₹468 Cr
QoQ -7.9%YoY +39.0%
Operating Margin
17.4%
QoQ -215 bpsYoY -490 bps

AI Quarterly Scorecard™

62
/ 100
Healthy
Revenue Momentum89
Profit Growth48
Margin Expansion29
Growth Consistency99
Operating Efficiency45
Financial Stability64

Computed deterministically from the last 10 reported quarters.

Quarterly Business Momentum

Revenue & Growth
  • Revenue has increased for 7 consecutive quarters.
  • Revenue of ₹2,684 Cr is 78.0% higher year-on-year.
  • Revenue has compounded at 40.6% annualised over the last 10 quarters.
  • Revenue is at its highest level in 10 quarters.
Profitability
  • Net profit of ₹207 Cr is 5.4% above the same quarter last year.
  • Profit growth is trailing revenue growth this quarter.
  • Net profit has compounded at 3.8% annualised across the period.
Margins
  • Operating margin stands at 17.4% in Q1 FY2027.
  • Operating margin compressed by 490 bps year-on-year.
  • Over the last two years operating margin has contracted by 572 bps.
  • PBT margin is 9.7%.
Operating Efficiency
  • Expenses grew 89.3% against revenue growth of 78.0%.
  • Operating profit of ₹468 Cr is 39.0% higher year-on-year.
  • Operating leverage has been under pressure recently.
Overall Momentum
  • 6 of the last 6 measured quarters delivered year-on-year revenue growth.
  • Overall quarterly business momentum scores 62/100 (Healthy) on the latest 10 quarters.
  • Business momentum remains positive heading into the next quarter.

Quarterly Financials

Last 10 Reported Quarters • All figures in ₹ Crore • Margins in %

MetricTrend
Latest
Q1 FY2027
Q4 FY2026Q3 FY2026Q2 FY2026Q1 FY2026Q4 FY2025Q3 FY2025Q2 FY2025Q1 FY2025Q4 FY2024
Revenue
Accelerating
2,684
2,5942,1511,6441,5071,4751,3351,3671,3061,246
Expenses
Accelerating
2,216
2,0861,7861,2431,1711,1181,0271,0581,004955
Operating Profit
Improving
468
508365401337358307309302291
Operating Margin
Stable
17.4%
19.6%17.0%24.4%22.3%24.2%23.0%22.6%23.1%23.4%
Other Income
Volatile
35
25-2924242018232426
Interest
Strong Uptrend
87
916542454137353428
Depreciation
Accelerating
156
15412287848370656165
Profit Before Tax
Improving
260
288149296232254219232231225
Tax
Volatile
53
642237355726333034
Net Profit
Improving
207
224127258197197193199201191
Net Margin
Stable
7.7%
8.6%5.9%15.7%13.1%13.4%14.5%14.5%15.4%15.3%
Source: Financial Intelligence (Structured Quarterly Data)Latest Quarter: Q1 FY2027Figures in ₹ Crore • Margins in %Automatically updated from Financial Intelligence · 2026-06-30

Key Takeaways

  • Revenue for the quarter surged by 75.86% year-on-year, reaching a record INR 2,594 Cr.
  • Operating profit reached INR 508 Cr, the highest quarterly figure in the company's reporting history.
  • Net profit saw a sharp sequential recovery of 76% following a relatively weak December 2025 quarter.
  • The balance sheet shows a massive expansion phase with borrowings rising to INR 5,857 Cr to fund growth.
  • Interest costs have nearly doubled year-on-year to INR 91 Cr, reflecting the increased leverage.
  • The company effectively maintained high volumes despite the margin compression from 24% to 20% compared to last March.
  • Depreciation increased significantly to INR 154 Cr, signaling the commissioning of new assets and capacities.

Management Guidance

The company is in an aggressive expansionary phase, shifting from a founder-led model to a professionalised multi-specialty powerhouse with a focus on digital health and insurance (NH-Atreya).

Sentiment Shift

Improving

A strong sequential rebound in net profit and record-breaking revenue growth offset concerns regarding rising debt levels and interest costs.

Expansionary
Capital Intensive
High Volume
Transitioning

Outlook

NH is moving toward more complex quaternary care and international expansion in the Cayman Islands. While near-term margins may be pressured by the gestation of new capacities and higher finance costs, the scale-up in revenue suggests strong market demand.

From the Annual Report (Key Quotes)

NH has transformed from a domestic cardiac-focused chain into a diversified multi-specialty healthcare powerhouse.

A significant international profit engine in the Cayman Islands continues to bolster performance.

The balance sheet is currently in an expansionary phase, reflecting aggressive brownfield and greenfield investments.

Official Quarterly Documents

Earnings Press Release
Official quarterly earnings release published by the company.
Press Release not available.
Earnings Call Transcript
Management discussion and analyst Q&A.
Open original

Ask AI about this quarter

Sign in to ask AI questions grounded on the official earnings release and call transcript.

This summary is AI-generated from Narayana Hrudayalaya Ltd.'s latest quarterly filing and earnings call. For informational purposes only — not investment advice.

← Back to Narayana Hrudayalaya Ltd. AI analysis